Posts found in:
Brad L. Schoenfeld
KO Client Cloudbreak Pharma Enters into Licensing Agreement with Santen
- KO Firm
- |
- September 3, 2024
KO client Cloudbreak Pharma, an innovative clinical-stage ophthalmology biotechnology company, recently announced that it has entered into a licensing agreement with Santen, a specialized company dedicated to eye health, to develop, manufacture, and commercialize its topical pterygium treatment. Cloudbreak founder and CEO Jinsong Ni said: “We are excited to partner…
FTC’s Non-Compete Ban Blocked for Employers Nationwide
- KO Firm
- |
- August 22, 2024
A Texas federal court has struck down the Federal Trade Commission’s (FTC) proposed nationwide ban on non-compete agreements, just weeks before it was set to go into effect on September 4. This decision maintains the status quo and allows employers across the country to enforce non-compete clauses in accordance with…
Employer Update: How to Plan for the FTC’s Non-Compete Ban
- KO Firm
- |
- May 7, 2024
In an effort to promote competition, protect workers’ rights, and foster innovation and new business formation, the Federal Trade Commission recently announced a significant rule aiming to ban non-competes between almost all employers and employees nationwide. If this regulation withstands existing and forthcoming legal scrutiny, employers won’t be able to…
KO Partner Brad Schoenfeld Named Top 25 Attorney in Colorado
- KO Firm
- |
- March 27, 2024
Congratulations to KO Law partner Brad Schoenfeld on being recognized as one of the “Top 25 Attorneys of Colorado” by Attorney Intel. Brad and the selected attorneys exemplify the depth of legal talent in Colorado and have specialized practices in a number of areas. Over the last 20 years at…
KO Client Predicine Collaborates with Janssen to Develop PredicineCARE™ for Bladder Cancer
- KO Firm
- |
- January 30, 2024
KO client Predicine, Inc., a leading molecular insights company committed to advancing precision medicine in oncology, recently announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company, to develop PredicineCARE™ as a companion diagnostic assay in localized bladder cancer. The collaboration represents progress in using comprehensive genomic profiling…
KO Pro Bono Client Elpida Treats Ultra-Rare Diseases for Children Worldwide
- KO Firm
- |
- November 29, 2023
KO pro bono client Elpida Therapeutics’ mission is to deliver gene therapies to patients with ultra-rare diseases that are non-commercially viable and overlooked by traditional biotech and pharmaceutical companies. By leveraging scientific advancements and gene therapies, Elpida aims to provide treatments for children and families that desperately and urgently need…
CO Employment Update: What Employers Need to Know about the POWR Act
- Niki Vinod Schwab
- |
- October 31, 2023
Companies with Colorado-based employees should be aware of the Protecting Opportunities and Workers’ Rights Act (“POWR Act”) that took effect on August 7, 2023. With the intent of “addressing discriminatory or unfair employment practices pursuant to Colorado’s anti-discrimination laws” (per the Bill’s summary), the POWR Act expands the Colorado Anti-Discrimination…
CO Employer Update: Healthy Families and Workplaces Act Expands Paid Leave
- KO Firm
- |
- September 27, 2023
If you’re an employer with Colorado-based employees, you’re likely aware of your obligations to provide certain paid sick time off, as required by the Colorado Healthy Families and Workplaces Act (HFWA). Whether you have an accrual-based policy or a ‘flexible time off’ policy, you’ll want to note the expansion of…